Ceregene

Develops AAV-based therapies for neurodegenerative and eye disorders

placeSan Diego, California, United States calendar_todayFounded 2001 groups30 employees language ceregene.com

Registered entities

Investor mix

7 investors on record; lead investors include Alta Partners, Hamilton BioVentures.

Investor typeCountShare
Venture capital571%
Private equity114%
Other / undisclosed114%
Coming soon